Literature DB >> 18688863

Impressive time-related influence of the Dutch screening programme on breast cancer incidence and mortality, 1975-2006.

Johannes D M Otten1, Mireille J M Broeders, Jacques Fracheboud, Suzie J Otto, Harry J de Koning, André L M Verbeek.   

Abstract

The aim of this study was to assess changes in the trends in breast cancer mortality and incidence from 1975 to 2006 among Dutch women, in relation to the implementation of the national breast cancer screening programme. Screening started in 1989 for women aged 50-69 and was extended to women aged 70-75 years in 1998 (attendance rate approximately >80%). A joinpoint Poisson regression analysis was used to identify significant changes in rates over time. Breast cancer mortality rates increased until 1994 (age group 35-84), but thereafter showed a marked decline of 2.3-2.8% per annum for the age groups 55-64 and 65-74 years, respectively. For the age group of 75-84 years, a decrease started in the year 2001. In women aged 45-54, an early decline in breast cancer mortality rates was noted (1971-1980), which is ongoing from 1992. For all ages, breast cancer incidence rates showed an increase between 1989 and 1993, mainly caused by the age group 50-69, and thereafter, a moderate increase caused by age group 70-74 years. This increase can partly be explained by the introduction of screening. The results indicate an impressive decrease in breast cancer mortality in the age group invited for breast cancer screening, starting to show quite soon after implementation.

Entities:  

Mesh:

Year:  2008        PMID: 18688863     DOI: 10.1002/ijc.23736

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  18 in total

Review 1.  The benefits and harms of breast cancer screening: an independent review.

Authors:  M G Marmot; D G Altman; D A Cameron; J A Dewar; S G Thompson; M Wilcox
Journal:  Br J Cancer       Date:  2013-06-06       Impact factor: 7.640

2.  Binding site of activators of the cystic fibrosis transmembrane conductance regulator in the nucleotide binding domains.

Authors:  O Moran; L J V Galietta; O Zegarra-Moran
Journal:  Cell Mol Life Sci       Date:  2005-02       Impact factor: 9.261

Review 3.  Endocrine-disrupting chemicals: associated disorders and mechanisms of action.

Authors:  Sam De Coster; Nicolas van Larebeke
Journal:  J Environ Public Health       Date:  2012-09-06

Review 4.  [Cardiovascular risk of androgen deprivation therapy for treatment of hormone-dependent prostate cancer : Differences between GnRH antagonists and GnRH agonists].

Authors:  C Tschöpe; B Kherad; F Spillmann; C A Schneider; B Pieske; F Krackhardt
Journal:  Herz       Date:  2016-04-15       Impact factor: 1.443

5.  Breast cancer screening: evidence of benefit depends on the method used.

Authors:  Philippe Autier; Mathieu Boniol
Journal:  BMC Med       Date:  2012-12-12       Impact factor: 8.775

Review 6.  Impact of mammographic screening on the detection of good and poor prognosis breast cancers.

Authors:  Laura J Esserman; Yiwey Shieh; Emiel J T Rutgers; Michael Knauer; Valesca P Retèl; Stella Mook; Annuska M Glas; Dan H Moore; Sabine Linn; Flora E van Leeuwen; Laura J van 't Veer
Journal:  Breast Cancer Res Treat       Date:  2011-09-04       Impact factor: 4.872

7.  Increasingly strong reduction in breast cancer mortality due to screening.

Authors:  G van Schoor; S M Moss; J D M Otten; R Donders; E Paap; G J den Heeten; R Holland; M J M Broeders; A L M Verbeek
Journal:  Br J Cancer       Date:  2011-02-22       Impact factor: 7.640

8.  Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database.

Authors:  Philippe Autier; Mathieu Boniol; Anna Gavin; Lars J Vatten
Journal:  BMJ       Date:  2011-07-28

9.  Recent changes in breast cancer incidence in Spain, 1980-2004.

Authors:  Marina Pollán; Roberto Pastor-Barriuso; Eva Ardanaz; Marcial Argüelles; Carmen Martos; Jaume Galcerán; María-José Sánchez-Pérez; María-Dolores Chirlaque; Nerea Larrañaga; Ruth Martínez-Cobo; María-Cres Tobalina; Enrique Vidal; Rafael Marcos-Gragera; Antonio Mateos; Isabel Garau; María-Dolores Rojas-Martín; Rosario Jiménez; Ana Torrella-Ramos; Josefina Perucha; Maria-Eugenia Pérez-de-Rada; Susana González; María-José Rabanaque; Joan Borràs; Carmen Navarro; Esther Hernández; Angel Izquierdo; Gonzalo López-Abente; Carmen Martínez
Journal:  J Natl Cancer Inst       Date:  2009-10-26       Impact factor: 13.506

10.  Breast Cancer Screening Program in Lithuania: Trends in Breast Cancer Mortality Before and During the Introduction of the Mammography Screening Program.

Authors:  Laura Steponavičienė; Rūta Briedienė; Rasa Vansevičiūtė-Petkevičienė; Daiva Gudavičienė-Petkevičienė; Ieva Vincerževskienė
Journal:  Acta Med Litu       Date:  2020-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.